Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard D Gelber

Showing results (1-10 of 217) with videos related to

Pageof 22
Sort By:
The New England Journal of Medicine|June 2, 2009
Endocrine therapy plus zoledronic acid in premenopausal breast cancerRichard D Gelber, Stefan Aebi
Breast (Edinburgh, Scotland)|November 17, 2009
Facilitating consensus by examining patterns of treatment effectsRichard D Gelber, Shari Gelber, , et al.
Clinical Trials (London, England)|January 31, 2015
Marvin Zelen, 1927-2014Richard D Gelber, Shari Gelber
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 12, 2014
Time to initiation of adjuvant chemotherapy for early breast cancer and outcome: the earlier, the better?Marco Colleoni, Richard D Gelber
Biostatistics (Oxford, England)|June 23, 2004
Patterns of treatment effects in subsets of patients in clinical trialsMarco Bonetti, Richard D Gelber
Nature Reviews. Clinical Oncology|September 6, 2012
Breast cancer: Anastrozole and fulvestrant--combination to unlock efficacyAron Goldhirsch, Richard D Gelber
Breast (Edinburgh, Scotland)|November 27, 2004
Life with consequences of breast cancer: pregnancy during and after endocrine therapiesAron Goldhirsch, Richard D Gelber
Breast (Edinburgh, Scotland)|October 4, 2005
Predicting response to systemic treatments: learning from the past to plan for the futureMeredith M Regan, Richard D Gelber
Breast (Edinburgh, Scotland)|August 28, 2007
Using clinical trial data to tailor adjuvant treatments for individual patientsMeredith M Regan, Richard D Gelber,
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 25, 2007
Problems with the progesterone receptor in practice?V Craig Jordan, Richard D Gelber
Pageof 22

Showing results (1-10 of 217) with videos related to

Sort By:
Pageof 22
The New England Journal of Medicine|June 2, 2009
Endocrine therapy plus zoledronic acid in premenopausal breast cancerRichard D Gelber, Stefan Aebi
Breast (Edinburgh, Scotland)|November 17, 2009
Facilitating consensus by examining patterns of treatment effectsRichard D Gelber, Shari Gelber, , et al.
Clinical Trials (London, England)|January 31, 2015
Marvin Zelen, 1927-2014Richard D Gelber, Shari Gelber
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 12, 2014
Time to initiation of adjuvant chemotherapy for early breast cancer and outcome: the earlier, the better?Marco Colleoni, Richard D Gelber
Biostatistics (Oxford, England)|June 23, 2004
Patterns of treatment effects in subsets of patients in clinical trialsMarco Bonetti, Richard D Gelber
Nature Reviews. Clinical Oncology|September 6, 2012
Breast cancer: Anastrozole and fulvestrant--combination to unlock efficacyAron Goldhirsch, Richard D Gelber
Breast (Edinburgh, Scotland)|November 27, 2004
Life with consequences of breast cancer: pregnancy during and after endocrine therapiesAron Goldhirsch, Richard D Gelber
Breast (Edinburgh, Scotland)|October 4, 2005
Predicting response to systemic treatments: learning from the past to plan for the futureMeredith M Regan, Richard D Gelber
Breast (Edinburgh, Scotland)|August 28, 2007
Using clinical trial data to tailor adjuvant treatments for individual patientsMeredith M Regan, Richard D Gelber,
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 25, 2007
Problems with the progesterone receptor in practice?V Craig Jordan, Richard D Gelber
Pageof 22